ReviewAmerican journal of nephrology2008
The role of anemia management in improving outcomes for African-Americans with chronic kidney disease.
Review in American journal of nephrology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 24 citations in OpenAlex.
- Trends in Anemia and Kidney Failure Related Mortality (1999-2023): A 25-Year Retrospective Analysis.Journal of immigrant and minority health · 2026Article
- Continuous Glucose Monitoring Metrics and Hemoglobin A1c Relationship in Patients with Type 2 Diabetes Treated by Hemodialysis.Diabetes technology & therapeutics · 2024Observational
- The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study.Transplant international : official journal of the European Society for Organ Transplantation · 2019Article
- Hemodialysis Disparities in African Americans: The Deeply Integrated Concept of Race in the Social Fabric of Our Society.Seminars in dialysis · 2017Review
- International Comparisons to Assess Effects of Payment and Regulatory Changes in the United States on Anemia Practice in Patients on Hemodialysis: The Dialysis Outcomes and Practice Patterns Study.Journal of the American Society of Nephrology : JASN · 2016Article
- Comparative changes in treatment practices and clinical outcomes following implementation of a prospective payment system: the STEPPS study.BMC nephrology · 2015Article
- Has dialysis payment reform led to initial racial disparities in anemia and mineral metabolism management?Journal of the American Society of Nephrology : JASN · 2015Article
- Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications.Journal of drug delivery · 2012Article
- Using race as a case-mix adjustment factor in a renal dialysis payment system: potential and pitfalls.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2010Article
- Hemoglobin differences by race in children with CKD.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2010Article
- Ethnic differences in anemia among patients with diabetes mellitus: the Diabetes Study of Northern California (DISTANCE).American journal of hematology · 2010Article
- Possible effects of the new Medicare reimbursement policy on African Americans with ESRD.Journal of the American Society of Nephrology : JASN · 2009Article
- Management of anemia in patients with diabetic kidney disease: A consensus statement.Indian journal of endocrinology and metabolismReview
- Qualitative assessment of red blood cell parameters for signs of anemia in patients with chronic periodontitis.Journal of International Society of Preventive & Community DentistryArticle
- Resistance of dialyzed patients to erythropoietin.Revista brasileira de hematologia e hemoterapiaArticle
- Controversies in timing of dialysis initiation and the role of race and demographics.Seminars in dialysisReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
Abstract
Chronic kidney disease (CKD) is a serious threat to African-American public health. In this population CKD progresses to end-stage renal disease (ESRD) at quadruple the rate in Caucasians. Factors fueling progression to ESRD include diabetes and hypertension, which show high prevalences and accelerated renal damage in African- Americans, as well as possible nutritional, socioeconomic, and genetic factors. Anemia, a common and deleterious complication of CKD, is more prevalent and severe in African-American than Caucasian patients at each stage of the disease. Proactive management of diabetes, hypertension, anemia, and other complications throughout the course of CKD can prevent or delay disease progression and alleviate the burden of ESRD for the African-American community. Currently, African-Americans with CKD are less likely than Caucasian patients to receive anemia treatment before and after the onset of dialysis. Although African-Americans often require higher doses of erythropoiesis-stimulating agents, this may result from late treatment initiation, lower hemoglobin levels, or the presence of comorbidities such as diabetes and inflammation, although racial differences in response cannot be excluded. This review explores racial-specific challenges and potential solutions in renal anemia management to improve outcomes in African-American patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.